CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to ZLDPF

Phase 3

Development Phase

0

Upcoming Catalysts

1

Historical Events

1

Regulatory Approvals

Development History
Past
days
ZEALRegulatory
Phase 3✅Approved

Zeydovio EMA Unknown

Glepaglutide
Sep 17
Source
Competitive Landscape

1 competitor in Short Bowel Syndrome

View Full Landscape
Drug Information

Target Indication

Short Bowel Syndrome

Clinical Trial

NCT04881825

Last updated: 2/15/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Regulatory Approvals
EMAPending

Zeydovio

Treatment of adults with Short Bowel Syndrome

View on EMA
Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.